Page last updated: 2024-08-24

zileuton and 7-hydroxy-5,11-dioxotetranorprostane-1,16-dioic acid

zileuton has been researched along with 7-hydroxy-5,11-dioxotetranorprostane-1,16-dioic acid in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akpa, EG; Bosworth, BP; Boyle, JO; Brown, PH; Dannenberg, AJ; Duffield-Lillico, AJ; Kingsley, PJ; Knutson, A; Marnett, LJ; Milne, GL; Mohebati, A; Szabo, E; Zhou, XK1

Trials

1 trial(s) available for zileuton and 7-hydroxy-5,11-dioxotetranorprostane-1,16-dioic acid

ArticleYear
Effect of zileuton and celecoxib on urinary LTE4 and PGE-M levels in smokers.
    Cancer prevention research (Philadelphia, Pa.), 2013, Volume: 6, Issue:7

    Topics: Adult; Arachidonate 5-Lipoxygenase; Biomarkers; Celecoxib; Chromatography, Liquid; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Female; Humans; Hydroxyurea; Leukotriene E4; Lipoxygenase Inhibitors; Male; Maximum Tolerated Dose; Prognosis; Prostaglandins; Pyrazoles; Smoking; Sulfonamides; Tandem Mass Spectrometry

2013